By downregulating CDK2 and these two lncRNAs, GR may simultaneously inhibit tumor proliferation and reverse the immunosuppressive state, providing a theoretical rationale for exploring its combination with immune checkpoint inhibitors in the treatment of CC. Here, CDK2 is linked to neoplasm.